Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 20, 2021

SELL
$232.65 - $254.58 $220,552 - $241,341
-948 Closed
0 $0
Q1 2021

Apr 14, 2021

SELL
$232.09 - $256.88 $3.82 Million - $4.23 Million
-16,471 Reduced 94.56%
948 $230,000
Q4 2020

Jan 19, 2021

BUY
$221.92 - $245.94 $237,010 - $262,663
1,068 Added 6.53%
17,419 $4.36 Million
Q3 2020

Oct 13, 2020

SELL
$215.77 - $276.76 $86,308 - $110,704
-400 Reduced 2.39%
16,351 $3.81 Million
Q2 2020

Jul 09, 2020

BUY
$219.9 - $263.41 $309,399 - $370,617
1,407 Added 9.17%
16,751 $4.01 Million
Q1 2020

May 05, 2020

SELL
$195.69 - $279.01 $1.37 Million - $1.96 Million
-7,016 Reduced 31.38%
15,344 $3.53 Million
Q4 2019

Jan 14, 2020

BUY
$236.45 - $266.82 $1.34 Million - $1.51 Million
5,671 Added 33.98%
22,360 $3.7 Million
Q3 2019

Nov 06, 2019

BUY
$230.58 - $256.08 $14,526 - $16,133
63 Added 0.38%
16,689 $4.22 Million
Q2 2019

Jul 12, 2019

BUY
$217.4 - $246.08 $80,003 - $90,557
368 Added 2.26%
16,626 $4.19 Million
Q1 2019

Apr 09, 2019

SELL
$206.05 - $248.17 $70,469 - $84,874
-342 Reduced 2.06%
16,258 $4.06 Million
Q4 2018

Jan 28, 2019

BUY
$204.73 - $257.93 $98,884 - $124,580
483 Added 3.0%
16,600 $3.74 Million
Q3 2018

Oct 10, 2018

SELL
$233.07 - $256.0 $132,849 - $145,920
-570 Reduced 3.42%
16,117 $4.21 Million
Q2 2018

Jul 17, 2018

SELL
$208.1 - $233.85 $196,862 - $221,222
-946 Reduced 5.36%
16,687 $4 Million
Q1 2018

Apr 19, 2018

SELL
$205.46 - $240.27 $483,447 - $565,355
-2,353 Reduced 11.77%
17,633 $3.82 Million
Q4 2017

Jan 22, 2018

BUY
$189.0 - $222.64 $3,024 - $3,562
16 Added 0.08%
19,986 $4.28 Million
Q3 2017

Oct 13, 2017

BUY
$186.89 - $198.9 $3.73 Million - $3.97 Million
19,970
19,970 $3.91 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Univest Financial Corp Portfolio

Follow Univest Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Univest Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Univest Financial Corp with notifications on news.